摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,6S)-3-isopropyl-1,4-diazabicyclo<4.4.0>decane-2,5-dione | 133321-93-4

中文名称
——
中文别名
——
英文名称
(3S,6S)-3-isopropyl-1,4-diazabicyclo<4.4.0>decane-2,5-dione
英文别名
3-isopropyl-hexahydro-pyrido[1,2-a]pyrazine-1,4-dione;cyclo-(L-Valyl-L-pipecoloyl);(3S,9AS)-3-isopropylhexahydro-4H-pyrido[1,2-a]pyrazine-1,4(6H)-dione;(3S,9aS)-3-propan-2-yl-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazine-1,4-dione
(3S,6S)-3-isopropyl-1,4-diazabicyclo<4.4.0>decane-2,5-dione化学式
CAS
133321-93-4
化学式
C11H18N2O2
mdl
——
分子量
210.276
InChiKey
HCWJEBCUDUYPTA-IUCAKERBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.52
  • 重原子数:
    15.0
  • 可旋转键数:
    1.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    49.41
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为产物:
    描述:
    trifluoroacetic acid salt of L-valyl-L-pipecolic acid methyl ester碳酸氢钠 作用下, 反应 2.0h, 以60%的产率得到(3S,6S)-3-isopropyl-1,4-diazabicyclo<4.4.0>decane-2,5-dione
    参考文献:
    名称:
    (3S,6S)-3-Isopropyl-1,4-diazabicyclo[4.4.0]decane-2,5-dione, C11H18N2O2: Bayesian statistics in data analysis
    摘要:
    C11H18N2O2, M(r) = 210.3, monoclinic, P2(1), a = 10.503 (4), b = 10.464 (7), c = 11.012 (4) angstrom, beta = 110.74 (2)-degrees, V = 1132 (1) angstrom 3, Z = 4, D(x) = 1.234 Mg m-3, lambda(Mo K-alpha) = 0.71073 angstrom, mu = 0.10 mm-1, F(000) = 456, room temperature, wR = 0.058, R = 0.102 for 2518 observed reflections out of 2538 measured, and 270 variables. The compound, for which the synthesis is also reported, consists of a piperidine ring in the chair conformation and a diketopiperazine ring in a very shallow boat form with C(3) and C(6) as bowsprits. The two rings are cis fused. The isopropyl group, pseudo-axially bonded, is folded over the diketopiperazine ring. The unit cell contains two symmetrically independent molecules A and B. Infinite chains, consisting exclusively either of type A or type B molecules, are linked by intermolecular N(4)-H...O(1) bonds. To compensate for the systematic weakness of reflections with h + l = odd, a new data analysis scheme was employed, based on Bayesian statistics. It led to an employed, based on Bayesian statistics. It led to an increase in the number of observed reflections from 1155 to 2518. The comparison between a refinement based on 1155 and one based on 2518 reflections showed that the Bayesian re-evaluation of data decreases the final e.s.d.'s considerably and does not create any detectable artefacts.
    DOI:
    10.1107/s0108768190007868
点击查看最新优质反应信息

同类化合物

麦可弗汀A 罗哌卡因杂质 六氢-2-甲基-2H-吡啶并[1,2-a]吡嗪-1,6-二酮 八氢吡啶并〔1,2-A〕吡嗪-6-酮 八氢吡啶并[1,2-a]吡嗪 八氢-吡啶并[1,2-A]吡嗪-4-酮盐酸盐 八氢-6H-吡啶并[1,2-a]吡嗪-6-酮盐酸盐 八氢-3-甲基-2H-吡啶并[1,2-a]吡嗪 八氢-2H-吡啶并[1,2-a]吡嗪二盐酸盐 八氢-2H-吡啶并[1,2-a]吡嗪-6-甲醇 7-甲氧基辛a氢-2H-吡啶并[1,2-a]吡嗪-2-胺 7-乙基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 6-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 4H-吡唑[1,2-A]吡嗪-4-八氢酮 3-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 2-硝基八氢-2H-吡啶并[1,2-a]吡嗪 2-乙基六氢-2H-吡啶并[1,2-a]吡嗪-1(6H)-酮 2-(9-甲基-3,9-二氮杂双环[3.3.1]壬-3-基)乙胺 2-(4-甲硫基唑-5-基)乙基丁酸酯 2,3,4,6,7,8,9,9alpha-八氢-1H-吡啶并[1,2-a]吡嗪-3-基甲醇 1,1'-联苯基,2-乙基-5-甲氧基- (R)-八氢吡啶并[1,2-A〕吡嗪二盐酸盐 (9aS)-八氢-4H-吡啶并[1,2-a]吡嗪-4-酮 (9aR)-八氢-2H-吡啶并[1,2-a]吡嗪 (9SS)-八氢-2-吡啶-吡嗪盐酸盐[1,2-A] (7r,9as)-八氢-2H-吡啶并[1,2-a]吡嗪-7-甲醇 (3S,6S)-3-苄基-1,4-二氮杂双环[4.4.0]癸烷-2,5-二酮 ((7S,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-7-基)甲醇 ((6R,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-6-基)甲醇 cyclo-(D-Leu-D-Pip) (3S,9aR)-hexahydro-3-methyl-6H-pyrido[1,2-a]pyrazine-1,4-dione (9aS)-2-benzyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine 3-[3-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-(2-chloro-3-fluoroanilino)cyclobut-3-ene-1,2-dione (7R,9aS)-trans-7-(3-morpholin-4-ylmethylphenoxymethyl)-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid tert-butyl ester 3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione 3-Chinolizidin-1-yl-2-methylindol 2-propyl-octahydro-pyrido[1,2-c][1,3,6]oxadiazocine (8R,9aS)-2-benzyl-3,3-dioxido-1-oxooctahydropyrrolo[2,1-d][1,2,5]thiadiazepin-8-yl cyclohexylcarbamate 2-(5-Amino-2-methoxy-phenyl)-hexahydro-pyrido[1,2-a]pyrazin-3-one 14α-hydroxy-15α-methyl-16β-methylsulfinyl-17-oxomarcfortine A (1S,7S,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one (4-Aminophenyl)-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 3-Benzylaminomethyl-chinolizidin rac-(4aR,8aR)-1-(piperidin-3-yl)-decahydroquinoline (1S,7R,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one N-((1R,2S,5R)-2-((S)-3-amino-2-oxopyrrolidin-1-yl)-5-(isopropylamino)cyclohexyl)acetamide 2-tert-butylperhydroimidazolo<3,4-a>pyridine 1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl-(2-chloro-5-phenylthiophen-3-yl)methanone 3-[2-oxo-2-[5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5,9-diazaspiro[2.6]nonan-9-yl]ethyl]thiazolidine-2,4-dione